Organigram Holdings reported CAD9.15M in Debt for its fiscal quarter ending in June of 2025.


Debt Change Date
Acasti Pharma USD 0 0 Sep/2024
Alaunos Therapeutics USD 0 0 Dec/2024
Aurora Cannabis CAD 101.63M 648K Jun/2025
Avita Medical AUD 45.98M 895K Dec/2024
Canopy Growth CAD 327.8M 161.87M Jun/2025
Cronos Group USD 2.01M 2.01M Jun/2025
Dianthus Therapeutics USD 1.33M 161K Jun/2025
Ionis Pharmaceuticals USD 1.42B 169.27M Jun/2025
IQVIA Holdings USD 15.49B 1.16B Jun/2025
Knight Therapeutics CAD 58.22M 109K Sep/2024
Moderna USD 741M 4M Jun/2025
Organigram Holdings CAD 9.15M 35.6M Jun/2025
Organon & Co USD 8.9B 60M Jun/2025
Revvity USD 3.17B 17.91M Mar/2025
Tectonic Therapeutic USD 876K 115K Dec/2024
Tilray USD 351.72M 15.26M Nov/2024
Viatris USD 14.76B 580.1M Jun/2025
Xeris Pharmaceuticals USD 257.22M 10.01M Jun/2025